Ciplavasc 5 mg AND 10 mg Tablets
PDF Leaflet Revision Date: 18 December 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of infections caused by susceptible strains.
Dosage (summary)
Adults: usual 2 g daily in 2 doses; max 12 g. Gonorrhea: 1 g single dose.
Onset of Action / Duration
Onset: 30 mins, Duration: 6-8 hours
Special Populations
- Renal impairment
- Elderly
Pregnancy & Breastfeeding
Caution in pregnancy; excreted in breast milk.
Key Drug Interactions
- Increased nephrotoxicity with aminoglycosides
- Probenecid increases serum concentration
Contraindications
- Allergy to cephalosporins
Common side effects
- Hypersensitivity reactions
- Skin rashes
- Nausea
- Diarrhea
Counselling Points
- Report any allergic reactions
- Take as prescribed
- Avoid mixing with other antibiotics
Serious warnings
- Risk of pseudomembranous colitis
- Monitor for allergic reactions
Important Disclaimer
The Ciplavasc 5 mg AND 10 mg Tablets professional information leaflet below is the property of Cipla Medpro and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
